Search
OriGene
LDLR Monoclonal Antibody (OTI7C5), TrueMAB™
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Additional Information:
{{banner.description}}
FIGURE: 1 / 3
LDLR Antibody (TA812510) in WB
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LDLR (RC200006, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 µg per lane) were separated by SDS-PAGE and immunoblotted with anti-LDLR. (1. Positive lysates LY400183 (100 µg) and LC400183 (20 µg) can be purchased separately from OriGene.
Product Details
TA812510
Applications
Tested Dilution
Publications
Product Specifications
Species Reactivity
Human
Host/Isotype
Mouse
/ IgG1
Class
Monoclonal
Type
Antibody
Clone
OTI7C5
Immunogen
Full length human recombinant protein of human LDLR produced in HEK293T cell.
Conjugate
Form
Liquid
Concentration
1 mg/mL
Amount
100 µg
Purification
Affinity chromatography
Storage buffer
PBS with 1% BSA, 50% glycerol
Contains
0.02% sodium azide
Storage conditions
-20°C, Avoid Freeze/Thaw Cycles
Shipping conditions
Ambient (domestic); Wet ice (international)
Target Information
The low density lipoprotein receptor (LDL-R) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in the LDL-R gene cause the autosomal dominant disorder, familial hypercholesterolemia. Along with SCARB1, CLDN1, and the tetraspanin superfamily member CD81, LDL-R has been reported to be an entry factor for the Hepatitis C virus. At least three isoforms of LDL-R are known to exist.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
References (0)
Have you cited this product in a publication?
Let us know so we can reference it here.
Bioinformatics
Protein Aliases: LDL receptor; ldl-r; Low-density lipoprotein receptor; low-density lipoprotein receptor class A domain-containing protein 3; unnamed protein product
Gene Aliases: FH; FHC; FHCL1; LDLCQ2; LDLR
UniProt ID: (Human) P01130
Entrez Gene ID: (Human) 3949
beta-amyloid binding
virus receptor activity
protease binding
low-density lipoprotein receptor activity
calcium ion binding
protein binding
low-density lipoprotein particle binding
very-low-density lipoprotein particle receptor activity
clathrin heavy chain binding
identical protein binding
binding, bridging
lipoprotein particle binding
retinoid metabolic process
negative regulation of receptor recycling
lipid metabolic process
lipid transport
endocytosis
receptor-mediated endocytosis
phagocytosis
long-term memory
steroid metabolic process
cholesterol metabolic process
negative regulation of macromolecule metabolic process
positive regulation of gene expression
negative regulation of gene expression
positive regulation of triglyceride biosynthetic process
regulation of phosphatidylcholine catabolic process
negative regulation of low-density lipoprotein particle clearance
phospholipid transport
intestinal cholesterol absorption
cholesterol transport
plasma lipoprotein particle clearance
low-density lipoprotein particle clearance
high-density lipoprotein particle clearance
lipoprotein metabolic process
lipoprotein catabolic process
cholesterol homeostasis
viral entry into host cell
artery morphogenesis
positive regulation of inflammatory response
negative regulation of multicellular organismal process
regulation of protein metabolic process
negative regulation of protein metabolic process
establishment of localization in cell
artery development
response to caloric restriction
negative regulation of astrocyte activation
cholesterol import
cellular response to fatty acid
cellular response to low-density lipoprotein particle stimulus
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport
regulation of cholesterol metabolic process
beta-amyloid clearance
amyloid-beta clearance by cellular catabolic process
negative regulation of microglial cell activation
positive regulation of lysosomal protein catabolic process
negative regulation of amyloid fibril formation
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Performance Guarantee
If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Learn more
We're here to help
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support